Industrial Goods » Industrial Electronics | OWC Pharmaceutical Research Corp.

OWC Pharmaceutical Research Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
50.00
-
7
Cost of Goods Sold (COGS) incl. D&A
-
2.70
9.10
9.70
8.30
7
Gross Income
-
2.70
9.10
40.30
8.30
7
SG&A Expense
231.30
5,030.80
1,642.30
2,138.40
4,545.40
3,564
EBIT
231.30
5,033.60
1,651.40
2,098.10
4,553.70
3,571
Non Operating Income/Expense
-
-
-
197.30
4.70
826
Interest Expense
87.00
37.20
3.60
-
-
-
Pretax Income
318.30
5,070.70
1,655.00
2,287.30
4,558.40
10,258
Consolidated Net Income
318.30
5,070.70
1,655.00
2,287.30
4,558.40
10,258
Net Income
318.30
5,070.70
1,655.00
2,287.30
4,558.40
10,258
Net Income After Extraordinaries
318.30
5,070.70
1,655.00
2,287.30
4,558.40
10,258
Net Income Available to Common
318.30
5,070.70
1,655.00
2,287.30
4,558.40
12,705
EPS (Basic)
0.02
0.10
0.02
0.02
0.03
0.09
Basic Shares Outstanding
18,981.10
52,210.00
80,591.20
96,362.20
145,203.70
148,066.40
EPS (Diluted)
0.02
0.10
0.02
0.02
0.03
0.09
Diluted Shares Outstanding
18,981.10
52,210.00
80,591.20
96,362.20
145,203.70
148,066.40
EBITDA
231.30
5,030.80
1,642.30
2,088.40
4,545.40
3,564
Non-Operating Interest Income
-
0.10
-
8.10
-
-

About OWC Pharmaceutical Research

View Profile
Address
2 Ben Gurion Street
Ramat Gan TA 5257334
Israel
Employees -
Website http://www.owcpharma.com
Updated 07/08/2019
OWC Pharmaceutical Research Corp. engages in the research and development of cannabis-based medical products for the treatment of myeloma and psoriasis. It focuses on the provision of consulting services and the development of a cannabis soluble tablet delivery system. The company was founded on March 7, 2008 and is headquartered in Ramat Gan, Israel.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.